Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity.

Demura M, Bulun SE.

Mol Cell Endocrinol. 2008 Feb 13;283(1-2):127-32. doi: 10.1016/j.mce.2007.12.003. Epub 2007 Dec 8.

PMID:
18201819
[PubMed - indexed for MEDLINE]
2.

Activation of p53 by MEG3 non-coding RNA.

Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, Ansell PJ, Zhao J, Weng C, Klibanski A.

J Biol Chem. 2007 Aug 24;282(34):24731-42. Epub 2007 Jun 13.

PMID:
17569660
[PubMed - indexed for MEDLINE]
Free Article
3.

Pituitary tumours: findings from whole genome analyses.

Farrell WE.

Endocr Relat Cancer. 2006 Sep;13(3):707-16. Review.

PMID:
16954426
[PubMed - indexed for MEDLINE]
Free Article
4.

Mechanisms of disease: The pathogenesis of pituitary tumors.

Ezzat S, Asa SL.

Nat Clin Pract Endocrinol Metab. 2006 Apr;2(4):220-30. Review.

PMID:
16932287
[PubMed - indexed for MEDLINE]
5.

Cyclic AMP stimulates MEG3 gene expression in cells through a cAMP-response element (CRE) in the MEG3 proximal promoter region.

Zhao J, Zhang X, Zhou Y, Ansell PJ, Klibanski A.

Int J Biochem Cell Biol. 2006;38(10):1808-20. Epub 2006 May 17.

PMID:
16793321
[PubMed - indexed for MEDLINE]
6.

The 2004 World Health Organization classification of pituitary tumors: what is new?

Al-Shraim M, Asa SL.

Acta Neuropathol. 2006 Jan;111(1):1-7. Epub 2005 Nov 23. Review.

PMID:
16328527
[PubMed - indexed for MEDLINE]
7.

Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life.

Weaver IC, Champagne FA, Brown SE, Dymov S, Sharma S, Meaney MJ, Szyf M.

J Neurosci. 2005 Nov 23;25(47):11045-54.

PMID:
16306417
[PubMed - indexed for MEDLINE]
Free Article
8.

Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.

Astuti D, Latif F, Wagner K, Gentle D, Cooper WN, Catchpoole D, Grundy R, Ferguson-Smith AC, Maher ER.

Br J Cancer. 2005 Apr 25;92(8):1574-80.

PMID:
15798773
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors.

Zhao J, Dahle D, Zhou Y, Zhang X, Klibanski A.

J Clin Endocrinol Metab. 2005 Apr;90(4):2179-86. Epub 2005 Jan 11.

PMID:
15644399
[PubMed - indexed for MEDLINE]
10.

Akting and cycling: a tale of the pituitary.

Grossman AB, Korbonits M.

Horm Res. 2004;62 Suppl 3:117-23. Review.

PMID:
15539812
[PubMed - indexed for MEDLINE]
11.

A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain.

Seitz H, Royo H, Bortolin ML, Lin SP, Ferguson-Smith AC, Cavaillé J.

Genome Res. 2004 Sep;14(9):1741-8. Epub 2004 Aug 12.

PMID:
15310658
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Epigenetic programming by maternal behavior.

Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ.

Nat Neurosci. 2004 Aug;7(8):847-54. Epub 2004 Jun 27.

PMID:
15220929
[PubMed - indexed for MEDLINE]
13.

Mechanisms for pituitary tumorigenesis: the plastic pituitary.

Melmed S.

J Clin Invest. 2003 Dec;112(11):1603-18. Review.

PMID:
14660734
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Loss of expression of the growth inhibitory gene GADD45gamma, in human pituitary adenomas, is associated with CpG island methylation.

Bahar A, Bicknell JE, Simpson DJ, Clayton RN, Farrell WE.

Oncogene. 2004 Jan 29;23(4):936-44.

PMID:
14647444
[PubMed - indexed for MEDLINE]
15.

A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells.

Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR, Klibanski A.

J Clin Endocrinol Metab. 2003 Nov;88(11):5119-26.

PMID:
14602737
[PubMed - indexed for MEDLINE]
16.

Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12.

Lin SP, Youngson N, Takada S, Seitz H, Reik W, Paulsen M, Cavaille J, Ferguson-Smith AC.

Nat Genet. 2003 Sep;35(1):97-102. Epub 2003 Aug 24.

PMID:
12937418
[PubMed - indexed for MEDLINE]
17.

Epigenetic change in pituitary tumorigenesis.

Farrell WE, Clayton RN.

Endocr Relat Cancer. 2003 Jun;10(2):323-30. Review.

PMID:
12790793
[PubMed - indexed for MEDLINE]
Free Article
18.

Alternative splicing and imprinting control of the Meg3/Gtl2-Dlk1 locus in mouse embryos.

Croteau S, Charron MC, Latham KE, Naumova AK.

Mamm Genome. 2003 Apr;14(4):231-41.

PMID:
12682775
[PubMed - indexed for MEDLINE]
19.

Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors.

Gao ZH, Suppola S, Liu J, Heikkilä P, Jänne J, Voutilainen R.

J Clin Endocrinol Metab. 2002 Mar;87(3):1170-6.

PMID:
11889182
[PubMed - indexed for MEDLINE]
20.

Epigenetic analysis of the Dlk1-Gtl2 imprinted domain on mouse chromosome 12: implications for imprinting control from comparison with Igf2-H19.

Takada S, Paulsen M, Tevendale M, Tsai CE, Kelsey G, Cattanach BM, Ferguson-Smith AC.

Hum Mol Genet. 2002 Jan 1;11(1):77-86.

PMID:
11773001
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk